trimethylamine has been researched along with Stroke in 8 studies
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Excerpt | Relevance | Reference |
---|---|---|
"Although trimethylamine-N-oxide (TMAO) shows a notable correlation with cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain and necessitates further investigation." | 9.41 | The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. ( Duan, Y; Guo, Z; Hong, Y; Li, Y; Liu, N; Sun, Z; Xu, Q; Yang, K, 2023) |
" We aimed to evaluate whether residual risk of recurrent stroke of TMAO and its precursor choline remain among patients who received dual-antiplatelet therapy and intensive lipid-lowering therapy and with a low inflammation level (high-sensitivity C-reactive protein <2 mg/L on admission)." | 8.12 | Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy. ( Cheng, A; Jiang, X; Jin, A; Li, H; Li, K; Lin, J; Meng, X; Wang, Y; Xu, J; Xue, J; Zhao, M; Zheng, L, 2022) |
"Although trimethylamine-N-oxide (TMAO) shows a notable correlation with cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain and necessitates further investigation." | 5.41 | The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. ( Duan, Y; Guo, Z; Hong, Y; Li, Y; Liu, N; Sun, Z; Xu, Q; Yang, K, 2023) |
"There is increasing evidence for the association of trimethylamine-N-oxide (TMAO) with cognitive impairment after minor stroke or transient ischemic attack (TIA)." | 4.31 | Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack. ( Bao, Y; Huang, D; Jiang, L; Qv, S; Wang, J; Wang, L; Xu, G; Yang, J; Zhan, X, 2023) |
" We aimed to evaluate whether residual risk of recurrent stroke of TMAO and its precursor choline remain among patients who received dual-antiplatelet therapy and intensive lipid-lowering therapy and with a low inflammation level (high-sensitivity C-reactive protein <2 mg/L on admission)." | 4.12 | Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy. ( Cheng, A; Jiang, X; Jin, A; Li, H; Li, K; Lin, J; Meng, X; Wang, Y; Xu, J; Xue, J; Zhao, M; Zheng, L, 2022) |
"Increased levels of lactic acid, pyruvate, and TMAO may be related to the pathophysiological changes in the minor ischaemic stroke population." | 4.12 | Related factors based on non-targeted metabolomics methods in minor ischaemic stroke. ( Chen, C; Ding, L; Guo, J; Liu, H; Ma, Y; Qiao, X; Wang, J; Wang, M; Yang, T; Zhao, S, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 7 (87.50) | 2.80 |
Authors | Studies |
---|---|
Zhang, H | 1 |
Yao, G | 1 |
Xue, J | 1 |
Xu, J | 1 |
Zhao, M | 1 |
Jin, A | 1 |
Cheng, A | 1 |
Jiang, X | 1 |
Li, K | 1 |
Lin, J | 1 |
Meng, X | 1 |
Li, H | 1 |
Zheng, L | 1 |
Wang, Y | 1 |
Chen, C | 1 |
Qiao, X | 1 |
Guo, J | 1 |
Yang, T | 1 |
Wang, M | 1 |
Ma, Y | 1 |
Zhao, S | 1 |
Ding, L | 1 |
Liu, H | 1 |
Wang, J | 2 |
Lemaitre, RN | 2 |
Jensen, PN | 2 |
Mozaffarian, D | 2 |
Wang, L | 1 |
Zhan, X | 1 |
Jiang, L | 1 |
Xu, G | 1 |
Bao, Y | 1 |
Qv, S | 1 |
Yang, J | 1 |
Huang, D | 1 |
Wang, Z | 1 |
Fretts, AM | 1 |
Sitlani, CM | 1 |
Nemet, I | 1 |
Sotoodehnia, N | 1 |
de Oliveira Otto, MC | 1 |
Zhu, W | 1 |
Budoff, M | 1 |
Longstreth, WT | 1 |
Psaty, BM | 1 |
Siscovick, DS | 1 |
Hazen, SL | 1 |
Hong, Y | 1 |
Sun, Z | 1 |
Liu, N | 1 |
Yang, K | 1 |
Li, Y | 1 |
Xu, Q | 1 |
Guo, Z | 1 |
Duan, Y | 1 |
Tarchichi, T | 1 |
Wong, K | 1 |
Fisher, MM | 1 |
Palomo, P | 1 |
Zapata, F | 1 |
Bawle, EV | 1 |
2 reviews available for trimethylamine and Stroke
Article | Year |
---|---|
Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies.
Topics: Gastrointestinal Microbiome; Humans; Methylamines; Oxides; Risk Factors; Stroke | 2023 |
The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis.
Topics: Humans; Ischemic Stroke; Methylamines; Oxides; Stroke | 2023 |
1 trial available for trimethylamine and Stroke
Article | Year |
---|---|
Plasma Trimethylamine-
Topics: Aged; Atherosclerosis; Female; Humans; Ischemic Stroke; Methylamines; Oxides; Prospective Studies; R | 2023 |
5 other studies available for trimethylamine and Stroke
Article | Year |
---|---|
Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy.
Topics: C-Reactive Protein; Choline; Humans; Inflammation; Lipids; Methylamines; Oxides; Platelet Aggregatio | 2022 |
Related factors based on non-targeted metabolomics methods in minor ischaemic stroke.
Topics: Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Homocysteine; Humans; Hypertension; I | 2022 |
Letter to the editor about published meta-analysis of TMAO and stroke.
Topics: Gastrointestinal Microbiome; Humans; Oxides; Stroke | 2023 |
Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack.
Topics: Aged; Cognitive Dysfunction; Humans; Ischemic Attack, Transient; Male; Oxides; Retrospective Studies | 2023 |
Index of suspicion.
Topics: Adolescent; Anticoagulants; Diagnosis, Differential; Diet Therapy; Embolism, Paradoxical; Female; Ga | 2013 |